Daniel E. Abbott, MD, FACS

Professor

  • Surgical Director, UW Health Liver and Pancreas Center
  • Division of Surgical Oncology

abbott@surgery.wisc.edu
(608) 262-2025

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792

Education

  • MD, University of Washington School of Medicine, Seattle, Washington, 2003
  • General Surgery Residency, Northwestern University/Feinberg School of Medicine, Chicago, Illinois, 2010
  • Research Fellowship, Children's Memorial Research Center/Northwestern University, Division of Cancer Biology and Epigenomics, Chicago, Illinois, 2008
  • Surgical Oncology Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2012

Clinical Specialties

Dr. Abbott is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. Trained specifically in cancer surgery at The University of Texas MD Anderson Cancer Center, his clinical focus is on gastrointestinal malignancies, as well as melanoma and sarcoma. He performs both traditional and laparoscopic resections for cancers of the liver, pancreas, and stomach. As Director of Cytoreductive and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery, he is particularly interested in patients with peritoneal spread of appendiceal, colorectal and ovarian cancers. Dr. Abbott is active in a number of national organizations, including the Society of Surgical Oncology, the American Hepatopancreaticobiliary Association, the Association for Academic Surgery, and the Society of University Surgeons.

Research Interests

Dr. Abbott, a health services researcher, focuses on cost-effectiveness, systems efficiency, and socioeconomic disparity in cancer care. He is particularly interested in identifying opportunities to maintain or enhance cancer care using technology in a patient-centered manner and thereby helping patients access expert cancer care in more personalized settings.

Recent Publications

  • ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC.
    Schwartz PB, Abbott DE
    Ann Surg Oncol 2022 Jun 14;
    [PubMed ID: 35699815]

  • ASO Visual Abstract: Rethinking Routine Intensive Care After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: The Fiscal Argument.
    Schwartz PB, Stahl CC, Vidri RJ, Leverson GE, Puckett Y, Zafar SN, Varley P, Ronnekleiv-Kelly SM, Al-Niaimi A, Weber SM, Abbott DE
    Ann Surg Oncol 2022 Jun 14;
    [PubMed ID: 35701546]

  • Rethinking Routine Intensive Care After Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy: The Fiscal Argument.
    Schwartz PB, Stahl CC, Vidri RJ, Leverson GE, Puckett Y, Zafar SN, Varley P, Ronnekleiv-Kelly SM, Al-Niaimi A, Weber SM, Abbott DE
    Ann Surg Oncol 2022 Jun 07;
    [PubMed ID: 35672624]

  • Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN, Macedo FI, Seaton M, Wilson G, Hammill C, Martin RC, Maduekwe UN, Kim HJ, Maithel SK, Abbott DE, Ahmad SA, Kooby DA, Merchant NB, Datta J
    Ann Surg Oncol 2022 May 05;
    [PubMed ID: 35511392]

  • Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?
    Beal EW, Chen JC, Kim A, Johnston FM, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Clarke C, Staley C, Patel SH, Lambert L, Cloyd JM
    J Surg Res 2022 Sep; 277: 269-278
    [PubMed ID: 35525209]

All Publications on PubMed